Login / Signup

[Is it appropriate for the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)" to require HBeAg-negative chronic HBV-infected patients to be HBV DNA-negative?]

M LiuT X ZhaoJ W Geng
Published in: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology (2024)
Keyphrases
  • hepatitis b virus
  • liver failure
  • circulating tumor
  • clinical practice
  • cell free
  • replacement therapy
  • circulating tumor cells